CVS Ordered to Pay $290 Million for Medicare Fraud
A federal court has handed down a major financial blow to CVS Caremark, ordering the pharmacy benefit manager to pay nearly $290 million in damages and penalties for defrauding the Medicare Part D program. The ruling caps a whistleblower case that began more than a decade ago and underscores the steep consequences companies face for overbilling federal health programs.